Table 3.

Intervention effects on categorical variables by experimental condition¹, ².

Outcome	Total Sample %	Control %	Intervention %	Exp(B)	95% C.I.
Verified visit to discuss prostate cancer with physician	12.1	8.3	15.8	2.127***	1.152 – 3.925
Plan to test for prostate cancer pretest	60.2	59.3	61.1	1.076	.748 – 1.548
Plan to test for prostate cancer posttest	81.0	81.0	80.9	.994	.614 – 1.610
Testing benefits outweigh risks posttest	30.9	28.2	33.5	1.283	.848 – 1.942
Verified PSA 1-year follow-up	45.5	45.9	45.1	.965	.671 – 1.386
Verified PSA 2-year follow-up	64.7	66.7	62.7	.829	.564 – 1.218
Congruence between intention to test and verified PSA test 1-year follow-up	56.7	58.1	55.3	.891	.621 – 1.279
Congruence between intention to test and verified PSA test 2-year follow-up	59.2	59.3	59.0	.986	.686 – 1.417

Notes.

¹For all self-report data, the pre-test sample size was 490 (246 control group; 244 experimental group), whereas the post-test sample size was 431 (216 control group; 215 experimental group). However, the sample size was 490 (246 control group; 244 experimental group) for data using medical claims records.

²All analyses adjusted for the covariates education level and claims-verified PSA test prior to pretest.

^*p<.05

^**p<.01

^***p<.001